Firefighters are the heroes of our society, protecting us around the clock. But those 24-hour shifts are hard on the body and increase the risk of cardiometabolic diseases, such as heart disease and diabetes, as well as cancer. ...
Oct 4, 2022
0
71
Carbon monoxide is best known as a potentially deadly gas. However, in small doses it also has beneficial qualities: It has been shown to reduce inflammation and can help stimulate tissue regeneration.
Jun 29, 2022
0
51
A COVID-19 booster shot will provide strong and broad antibody protection against the range of omicron sublineage variants of the SARS-CoV-2 virus in circulation, two new studies using serum from human blood samples suggest.
May 18, 2022
1
122
Researchers have tested a variety of popular hacks for improving the fit of KN95 and surgical masks, and found that while some hacks do improve fit, they can also come at the cost of the wearer's comfort.
Feb 2, 2022
0
103
A preliminary US study of nearly 70,000 COVID positive people showed a substantially reduced risk of hospitalization and death from Omicron even after controlling for growing population immunity levels.
Jan 12, 2022
0
299
Northwestern University engineers have developed a new smart sensor platform for face masks that they are calling a "Fitbit for the face."
Jan 12, 2022
0
106
Next generation vaccines for COVID-19 should aim to induce an immune response against 'replication proteins', essential for the very earliest stages of the viral cycle, concludes new research carried out by UCL scientists.
Nov 10, 2021
0
391
In what is believed to be one of the largest studies of its kind, Johns Hopkins Medicine researchers have shown that antibody levels against SARS-CoV-2 (the COVID-19 virus) stay more durable—that is, remain higher over ...
Nov 1, 2021
2
233
More than half of the 236 million people who have been diagnosed with COVID-19 worldwide since December 2019 will experience post-COVID symptoms—more commonly known as "long COVID"—up to six months after recovering, according ...
Oct 13, 2021
1
496
A small, early study suggests that people who've already encountered SARS-CoV-2 may gain a big boost against COVID-19 if they get just one dose of the Pfizer vaccine—and that protection may extend to new viral variants.
Aug 11, 2021
2
298
